Related Experiment Video
Updated: May 2, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K
Advanced breast angiosarcoma completely responding to gemcitabine-containing chemotherapy
Zhi-Guo Luo1, Qian Wang1, Wei Peng1
1Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Breast Care (Basel, Switzerland)
|March 21, 2014
Summary
For anthracycline-resistant metastatic breast angiosarcoma, the gemcitabine, vincristine, and cisplatin (GVP) regimen shows promise. This chemotherapy option achieved complete response in lung metastases, offering a new treatment strategy.
Area of Science:
- Oncology
- Medical Case Reports
Background:
- Metastatic angiosarcoma, particularly anthracycline-resistant forms, lacks established second-line treatment standards.
- Improved response rates are crucial for patients with advanced angiosarcoma.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K